Sun Pharma to donate Rs 250 million worth of medicines and hand sanitizers

Company to donate Hydroxychloroquine, Azithromycin and other related drugs

445
Sun Pharma
Photo - Sun Pharmaceitical

Sun Pharma announced its commitment to donate Rs 250 million of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and hand sanitizers to support India’s COVID-19 pandemic response.

The press release also states that the company salutes the entire medical and support fraternity, including doctors, nurses and healthcare workers who are selflessly providing care to all affected patients in India. To help these front-line warriors, Sun Pharma has re-purposed its liquid manufacturing facility in India to produce high-quality hand sanitizers and will make them available to healthcare professionals serving their communities and the nation.

Sun Pharma is committed to fighting the COVID-19 pandemic and has instituted work from home for all team members who can work remotely at all its locations. The company urges people both in India and around the world not to hoard medicines, to make sure they are available to those in genuine need.

The company is committed to working closely with the governments and relevant stakeholders to ensure there is an uninterrupted supply of medicines. Sun Pharma is constituting a task force to handle the distribution of these products in India.

The National Task Force for COVID-19 has recommended the prophylactic use of HCQS for high-risk population. The approved indications of HCQS are malaria, lupus erythematosus and rheumatoid arthritis. The approved indications of Azithromycin are uncomplicated skin or skin structure infections, community-acquired pneumonia, and more. HCQS is currently being studied by the World Health Organization (WHO) for use in-conjunction with Azithromycin to treat COVID-19.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here